Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1993-09-07
2000-02-15
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
4242371, 4242561, 424497, 424499, 424810, 42840221, 42840224, 514885, 514889, 514958, 514963, A61K 952, A61K 39085, A61K 3912, A61K 3939
Patent
active
060249838
ABSTRACT:
A method, and compositions for use therein capable, of delivering a bioactive agent to an animal entailing the steps of encapsulating effective amounts of the agent in a biocompatible excipient to form microcapsules having a size less than approximately ten micrometers and administering effective amounts of the microcapsules to the animal. A pulsatile response is obtained, as well as mucosal and systemic immunity.
REFERENCES:
patent: 2738303 (1956-03-01), Blythe
patent: 3474777 (1969-10-01), Figge et al.
patent: 3823228 (1974-07-01), Ferris et al.
patent: 3887699 (1975-06-01), Yolles
patent: 3959457 (1976-05-01), Speaker et al.
patent: 4021364 (1977-05-01), Speiser et al.
patent: 4107288 (1978-08-01), Oppenheim et al.
patent: 4123519 (1978-10-01), Tribble et al.
patent: 4148876 (1979-04-01), Almeida et al.
patent: 4152413 (1979-05-01), Goodnow
patent: 4152414 (1979-05-01), Harris et al.
patent: 4152415 (1979-05-01), Harris et al.
patent: 4166800 (1979-09-01), Fong
patent: 4196188 (1980-04-01), Besins
patent: 4203968 (1980-05-01), Harris et al.
patent: 4209507 (1980-06-01), Ogino et al.
patent: 4269821 (1981-05-01), Kreuter et al.
patent: 4291016 (1981-09-01), Nougaret
patent: 4292298 (1981-09-01), Davis
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4326524 (1982-04-01), Drake, Jr. et al.
patent: 4349530 (1982-09-01), Royer
patent: 4367217 (1983-01-01), Gruber et al.
patent: 4384975 (1983-05-01), Fong
patent: 4389330 (1983-06-01), Tice et al.
patent: 4428925 (1984-01-01), Keith
patent: 4428926 (1984-01-01), Keith
patent: 4434153 (1984-02-01), Urquhart et al.
patent: 4439199 (1984-03-01), Amkraut et al.
patent: 4455142 (1984-06-01), Martins et al.
patent: 4479911 (1984-10-01), Fong
patent: 4484923 (1984-11-01), Amkraut et al.
patent: 4524060 (1985-06-01), Mughal et al.
patent: 4525339 (1985-06-01), Behl et al.
patent: 4526938 (1985-07-01), Churchill et al.
patent: 4530840 (1985-07-01), Tice et al.
patent: 4542025 (1985-09-01), Tice et al.
patent: 4559303 (1985-12-01), Aotani et al.
patent: 4585651 (1986-04-01), Beck et al.
patent: 4590170 (1986-05-01), Akiyoshi et al.
patent: 4610870 (1986-09-01), Jain et al.
patent: 4613500 (1986-09-01), Suzuki et al.
patent: 4650769 (1987-03-01), Kakimi et al.
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4681752 (1987-07-01), Melillo
patent: 4690682 (1987-09-01), Lim
patent: 4732763 (1988-03-01), Beck et al.
patent: 4764359 (1988-08-01), Lemelson
patent: 4783336 (1988-11-01), Margel et al.
patent: 4845042 (1989-07-01), Newman et al.
patent: 4919929 (1990-04-01), Beck
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4990336 (1991-02-01), Silvestri et al.
patent: 5075109 (1991-12-01), Tice et al.
patent: 5126147 (1992-06-01), Silvestri et al.
patent: 5384133 (1995-01-01), Boyes et al.
patent: 5417986 (1995-05-01), Reid et al.
patent: 5503841 (1996-04-01), Doyle et al.
patent: 5811128 (1998-09-01), Tice et al.
patent: 5814344 (1998-09-01), Tice et al.
patent: 5820883 (1998-10-01), Tice et al.
patent: 5853763 (1998-12-01), Tice et al.
Black et al., Immunogenicity of Ty21a Attenuated Salmonella Typhi Given With Sodium Bicarbonate or in Enteric-Coated Capsules, Dev. Biol. Stand., vol. 53, pp. 9-14 (1984).
Cox et al., IgA Antibody produced by Local Presentation of Antigen in Orally Primed Rats, Int.Archs.Allergy Appl.Immun., vol. 74, pp. 249-255 (1984).
Deasy, P., Microencapsulation and Related Drug Process, Drugs and the Pharmaceutical Sciences, vol. 20, Chapter 1, pp. 8-13 and Chapter 10, pp. 218-227, Ed. James Swarbrick, Marcel Dekker, Inc., New York (1984).
Kondo, A., Applications and Studies of Microcapsules, Chapter 3, pp. 18-20; In-Liquid Curing Coating Process (Orifice Process), Chapter 7, pp. 61 and 68; Microencapsulation Utilizing Phase Separation From an Aqueous Solution System, Chapter 8, pp. 70 and 90-92; Microencapsulation Utilizing In-Liquid Drying Process (Complex Emulstion Method), Chapter 10, pp. 106-109 and 118-119, Microcapsule Processing and Technology, Ed. J. Wade Van Walkenburg, Marcel Dekker, Inc., New York (1980).
Kreuter et al., New Adjuvants on a Polymethymethacrylate Base, Infection and Immunity, vol. 13, pp. 204-210 (Jan. 1976).
Kreuter et al., Long-Term Studies of Microencapsulated and Adsorbed Influenza Vaccine Nanparticles, J.Pharm.Sci., vol. 70, No. 4, pp. 367-371 (Apr. 1981).
Lazzell et al., Immunization Against Influenza in Humans Using an Oral Enteric-Coated Killed Virus Vaccine, J.Biol.Standardization, vol. 12, pp. 315-321 (1984).
Preis et al., A Single-Step Immunization by Sustained Antigen Release, J.Immun.Methods, vol. 28, pp. 193-197 (1979).
Saffran et al., A New Approach to the Oral Administration of Insulin and Other Peptide Drugs, Science, vol. 233, pp. 1081-1085 (Sep. 5, 1986).
Sanders et al., Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide-co-glycolide) Microspheres, J.Pharm.Sci., vol. 73, No. 9, pp. 1294-1297 (Sep. 1984).
Shigeta et al., Plasma Immunoreactive Insulin After Intestinal Administration of .beta.-Naphthyl-Azo-Polystyrene-Insulin to the Rabbit, Endocrinology, Notes and Comments, vol. 91, No. 1, pp. 320-322 (1972).
Artursson et al., "Biodegradable Microspheres 11: Immune Response to a Heterologous and an Autologous Protein Entrapped in Polyacryl Starch Microparticles," J.Pharm.&Exp.Ther., vol. 234, No. 1, pp. 255-260 (1985).
Artursson et al., Biochemical and Cellular Effects of Degraded Starch Microspheres on Macrophages, Intl.J.Pharm., vol. 52, pp. 183-190 (1989).
Barratt et al., "Delivery of MDP-L-alanyl-cholesterol to Macrophages: Comparison of Liposomes and Nanocapcules," The Cancer Journal, vol. 2, No. 12, pp. 439-443 (Nov./Dec. 1989).
Chang T, "Biodegradable Semipermeable Microcapsules Containing Enzymes, Hormones, Vaccines, and Other Biologicals," J.Bioeng., vol. 1, pp. 25-32 (1976).
Cox et al., "Oral Induction of the Secretory Antibody Response by Soluble and Particulate Antigens," Int.Archs.AllergyAppl.Immun., vol. 75, pp. 126-131 (1984).
Damge et al., "New Approach for Oral Administration of Insulin with Polyalkylcyanoacrylate Nanocapsules as Drug Carrier," Diabetes, vol. 37, pp. 246-251 (Feb. 1988).
DeLuca et al., "Porous Biodegradable Microspheres for Parenteral Administration," Topics Pharm.Sci. 1987, D. Breimer et al., eds., pp. 429-442 (Aug./Sep. 1987).
Gundel et al., "Antigen-Coated Sepharose Beeds Induce Airway Eosinophilia and Airway Hyperesponsiveness in Cynomolgus Moneys," Am.Rev.Respir.Dis., vol. 140, pp. 629-633 (1989).
Harmia et al., "Nanoparticles as Drug Carriers in Ophthalmology," Pharm.Acta.Helv., vol. 62, No. 12, pp. 322-331 (1987).
Harmsen et al., "The Role of Macrophages in Particle Translocation from Lungs to Lymph Nodes," Science, vol. 230, No. 4731, pp. 1277-1281 (Dec. 1985).
Hay et al., "The Use of Radioactive Microspheres to Quantitate Hypermia in Dermal Inflammatory Sites," Proceedings of the Society for Experimental Biology and Medicine, vol. 150, pp. 641-644 (Oct.-Dec. 1975).
Hill et al., "Cell-Mediated Immunity to Soluble and Particulate Inhaled Antigens," Chem.Exp.Immunol., Blackwell Scientific Publications, vol. 38, pp. 332-341 (1979).
Illum et al., "Bioadhesive Microspheres as a Potential Nasal Drug Delivery System," Int.J.Pharm., vol. 39 pp. 189-199 (1987).
Juliano et al., "The Effect of Particle Size and Charge on the Clearance Rates of Liposomes and Liposome Encapsulated Drugs," Biochem.&Biophys.Res.Comm., P. Boyer et al., eds., vol. 63, No. 3, pp. 651-659 (1975).
Kanke et al., "Interaction of Microspheres with Blood Constituents and the Effect on Immune Response," Expo-Congr.Int.Technol.Pharm.3d., vol. 4, pp. 162-169 (1983).
Kanke et al., "Interaction of Microspheres with Blood Constituents II: Uptake of Biodegradable Particles by Macrophages," J.Parenteral Sci.&Tech., vol. 40, No. 4, pp. 114-118 (Jul./Aug. 1986).
Kanke et al., "Interaction of Microspheres with Blood Constituents III: Macrophage Phagocytosis of Various Types of Polymeric Drug Carriers," J.Parenteral Sci.&Tech., vol. 42, No. 5, pp. 157-165
Eldridge John H.
Gilley Richard M.
Staas Jay K.
Tice Thomas R.
Lovering Richard D.
Southern Research Institute
The UAB Research Foundation
LandOfFree
Composition for delivering bioactive agents for immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for delivering bioactive agents for immune response , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for delivering bioactive agents for immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1903761